news
(Bio)pharma continuous manufacturing market to reach $2.3 billion by 2027
The continuous manufacturing market for pharma/biopharma is expected to expand at a compound annual growth rate of 13.85 percent.
List view / Grid view
GEA Group
whitepaper
Product hub: Fast-track your pharmaceutical projects with DiGiTools
GEA’s digitally-enabled process optimisation tools improve the customer experience and expedite the successful completion of pharmaceutical research, development and production projects. This comprehensive suite of process simulations, digital twins, augmented/virtual reality systems and remote support solutions represents a safe and effective environment in which to achieve operational excellence, expedite FATs,…
news
Continuous wet granulation manufacturing collaboration
The new facility, built as part of a project called PROSPECT CP, will include blending and feeding of raw materials, twin screw wet granulation, drying and ultimately tabletting...
product
Video: GEA interviewed at at CPhi 2014
Andrew Johnson speaks with Søren Terp Madsen, Area Sales Manager and Product Manager, Chemical Division - Pharma Spray Drying, GEA Niro at CPhi 2014...
article
Ingredients In-Depth Focus 2013
In this Ingredients In-Depth Focus: Revisiting a mutual recognition agreement approach for GMP inspections to secure the safety of the supply chain of APIs; Solid form diversity of commonly used tableting excipients and its impact...
news
GEA Diessel signs new contract with Julphar in Ras Al Khaimah
7 June 2010 | By The Words Workshop Ltd
GEA Diessel GmbH, has recently signed a US$17.6 million contract with Gulf Pharmaceutical Industries (Julphar) to provide processing equipment for the manufacture of insulin...
